For instance, in liver cancer, NAT10 stimulates the acetylation of the ACLY protein’s K468 site, which raises acetyl-CoA synthesis and triggers the transcription of drug-resistant genes, leading to chemotherapy resistance [31]. The gene discussed is ACLY; the disease is liver cancer.